MC (US) 3 LLC – Trademark Portfolio

Entity Type: 16

MC (US) 3 LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AQUCAR, UCARCIDE, and FUELSAVER. The owner is based in WILMINGTON, DE.

1209 ORANGE STREET

WILMINGTON, DE 19801

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FUELSAVER
FUELSAVER
Registered 1992
AQUCAR
AQUCAR
Registered 1982
UCARCIDE
UCARCIDE
Registered 1978

Trademark Classifications

MC (US) 3 LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does MC (US) 3 LLC have?

MC (US) 3 LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does MC (US) 3 LLC file in?

MC (US) 3 LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MC (US) 3 LLC's most well-known trademarks?

MC (US) 3 LLC's registered trademark portfolio includes well-known marks such as AQUCAR, UCARCIDE, and FUELSAVER. These are among 3 currently registered trademarks in the portfolio.

What is MC (US) 3 LLC's trademark registration success rate?

MC (US) 3 LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.